Literature DB >> 18819764

[Bilateral leg compartment syndrome due to severe myonecrosis caused by inappropriate use of simvastatin].

M Chochola1, J-C Lubanda, L Skalicka, P Varejka, J Horejs, T Prskavec, M Balík, M Semrád, A Linhart.   

Abstract

Bilateral leg compartment syndrome due to myonecrosis caused by inappropriate use of statins is a rare but potentially fatal complication of this lipid lowering medication. We report a case of a 39-year-old woman who presented with suspicious critical lower limb ischemia. Subsequently, bilateral leg compartment syndrome and myonecrosis developed. The primary cause of myonecrosis was due to misuse of simvastatin mistaken by the patient for a weight-reducing drug. Urgent fasciotomies were performed and the patient underwent urgent renal replacement therapy with continuous hemodialysis for acute renal failure due to myoglobinuria. After this complex treatment, the patient was discharged. She almost fully recovered with only a residual paresis of the left fibular nerve. According to literature, this is a unique case of bilateral compartment syndrome and myonecrosis with acute renal failure due to statin overdose leading to acute renal failure and bilateral fasciotomy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18819764     DOI: 10.1016/j.jmv.2008.07.092

Source DB:  PubMed          Journal:  J Mal Vasc        ISSN: 0398-0499


  3 in total

1.  Bilateral gluteal compartment syndrome following right total knee revision: a case report.

Authors:  Kristie D Osteen; Shireen H Haque
Journal:  Ochsner J       Date:  2012

2.  Gluteal compartment syndrome following drug-induced immobilization: a case report.

Authors:  Andreas Christos Panagiotopoulos; Ioannis Vrachnis; Pantelis Kraniotis; Minos Tyllianakis
Journal:  BMC Res Notes       Date:  2015-02-08

3.  Combined Upper Extremity and Gluteal Compartment Syndrome Following Illicit Drug Abuse: A Retrospective Case Series.

Authors:  Matthew W Konigsberg; John D Mueller; Jordan A Lebovic; R Kumar Kadiyala
Journal:  Orthop Res Rev       Date:  2020-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.